Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples